The Four Key Reasons Healthcare Providers Recommend Stopping Reason #1: Animal studies raised red flags In pregnant rats and rabbits given GLP-1 medications, researchers observed increased pregnancy loss rates at high doses, skeletal abnormalities in some offspring, reduced fetal growth and birth weight, and developmental delays in some cases
Dose reduction or slowing the escalation timeline allows gradual neurological adjustment without abandoning therapy entirely
These insights reveal whether your body has a higher or lower natural demand for specific vitamins, allowing your care team to tailor supplementation beyond generic guidelines
Analysts note this could add 40 million new patients in the U.S
Your healthcare teampotentially including your primary care physician, endocrinologist, registered dietitian, and mental health professionalcan provide the comprehensive support needed for long-term success, whether you continue medication indefinitely or attempt maintenance without pharmacotherapy
Ensure that your medication informed consent discussion includes FDA information about the risks of compounded drugs generally and compounded semaglutide specifically
